 |
|
|
|
 |
 |
 |
|
Clinical and Translational Research Initiatives at NIH
As part of its Roadmap for Medical Research, NIH identified “Re-Engineering the Clinical and Translational Enterprise” as one of three themes that require collaboration of all NIH centers and institutes. The goal of this theme is to increase the speed and efficiency with which new developments and treatments are delivered to patients.
As a way to stimulate significant change in the clinical and translational research enterprise at academic medical centers, NIH announced a new program, the Clinical and Translational Science Award (CTSA) program, in mid-October 2005. By the year 2012, NIH expects to fund 60 CTSA’s across the country at the level of $500 million per year. Most of the budget for this initiative will come from redirected NIH Roadmap funds, existing clinical and translational programs, and other existing resources. The pool of NIH funds for investigator-initiated research will be preserved. In addition, existing GCRC, T32, K12 and other awards as appropriate will be consolidated into the CTSA. Drs. Buttrick, Goldstein, and Zwanziger are currently leading a cooperative UIC-wide effort involving participation from the six health science colleges, the Medical Center and other areas within the University to respond to the CTSA request for applications.
Currently, 36% of the NIH budget is spent funding clinical research projects and training clinical scientists. Despite a significant investment, NIH has recognized that the facilities and resources are not adequate to support existing clinical scientists and attract new investigators. The CTSA program aims to transform the discipline of clinical and translational research.
Please see the links below for additional information. For details about UIC initiatives in this area, please contact Research Development Services (rds@uic.edu).
 |
|